Growel Formulations Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 7.21 Cr
as on 17-07-2024
- Company Age 31 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 42.96 Cr
as on 17-07-2024
- Satisfied Charges ₹ 1.75 Cr
as on 17-07-2024
- Revenue 9.12%
(FY 2023)
- Profit -3.73%
(FY 2023)
- Ebitda -11.77%
(FY 2023)
- Net Worth 20.44%
(FY 2023)
- Total Assets 7.58%
(FY 2023)
About Growel Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 7.21 Cr.
The company currently has active open charges totaling ₹42.96 Cr. The company has closed loans amounting to ₹1.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vedadri Mudumbi, Ranga Mudumbi, and Padma Mudumbi serve as directors at the Company.
- CIN/LLPIN
U24239TG1993PTC015700
- Company No.
015700
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Apr 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Growel Formulations Private Limited offer?
Growel Formulations Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Animal Feed Supplement, Animal Feed.
Who are the key members and board of directors at Growel Formulations?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ranga Mudumbi  | Director | 24-Aug-2017 | Current |
| Vedadri Mudumbi | Whole-Time Director | 28-Dec-2001 | Current |
| Padma Mudumbi | Director | 24-Aug-2017 | Current |
Financial Performance and Corporate Structure Insights of Growel Formulations.
Growel Formulations Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.12% increase. The company also saw a slight decrease in profitability, with a 3.73% decrease in profit. The company's net worth Soared by an impressive increase of 20.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Growel Formulations?
In 2023, Growel Formulations had a promoter holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Growscience Nutrition And Health Private LimitedActive 1 year 11 months
Vedadri Mudumbi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 05 Jul 2022 | ₹2.78 M | Open |
Axis Bank Limited Creation Date: 01 Jul 2020 | ₹7.25 M | Open |
Axis Bank Limited Creation Date: 05 Jul 2019 | ₹1.18 Cr | Open |
How Many Employees Work at Growel Formulations?
Growel Formulations has a workforce of 104 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Growel Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Growel Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
